Contribution of lead to hypertension with renal impairment

The New England Journal of Medicine
V BatumanR P Wedeen

Abstract

Hypertension of unknown cause is generally termed "essential." Because hypertension has long been considered a possible complication of lead poisoning and the EDTA lead-mobilization test has proved to be a sensitive indicator of excessive body stores of lead, we used this test to evaluate cumulative past lead absorption in 48 men diagnosed as having essential hypertension. Patients who had hypertension with reduced renal function (i.e., serum creatinine level greater than 1.5 mg per deciliter [133 mumols per liter]) had significantly larger amounts of mobilizable lead than did patients who had hypertension without renal impairment. The increase in mobilizable lead was not due to the renal disease itself, since 22 control patients without a history of essential hypertension but with comparable renal impairment from known causes excreted significantly less lead chelate during the three-day test. These data suggest that lead may have an etiologic role in the renal disease of some patients usually designated as having "essential" hypertension.

References

Feb 1, 1978·The Journal of Pathology·J A InglisB T Emmerson
Jan 1, 1966·Lancet·A Breckenridge
Jan 1, 1982·Clinical and Experimental Dialysis and Apheresis·R P Wedeen
Feb 26, 1981·The New England Journal of Medicine·V BatumanR P Wedeen
May 27, 1982·The New England Journal of Medicine·S G RostandB A Pate

❮ Previous
Next ❯

Citations

Nov 1, 1994·American Journal of Industrial Medicine·A C dos SantosN A dos Santos
Nov 1, 1991·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·K SchärerU Ewers
May 1, 1992·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·R Nowack, E Ritz
Oct 1, 1993·Clinical Biochemistry·G Lockitch
Jan 1, 1992·Toxicology·C V Nolan, Z A Shaikh
Apr 1, 1985·Toxicology Letters·B C CampbellJ J Scott
Mar 1, 1989·Toxicology Letters·R A Goyer
Sep 5, 2002·Medical Hypotheses·H C Gonick, J R Behari
Aug 5, 1998·Kidney International·A Rastegar, M Kashgarian
Nov 5, 1992·The New England Journal of Medicine·J N van den Anker, P J Sauer
May 1, 1984·Archives of Environmental Health·K D Rosenman
Mar 1, 1988·Archives of Environmental Health·M Lippmann, G D Thurston
Sep 1, 1989·Archives of Environmental Health·J D OsterlohB Behrens
Sep 1, 1990·Archives of Environmental Health·R K SokasP Bloch
May 1, 2002·Current Opinion in Nephrology and Hypertension·Chi-Yuan Hsu
Jul 1, 1990·British Journal of Industrial Medicine·J StaessenC J Bulpitt
Mar 1, 1992·British Journal of Industrial Medicine·L GerhardssonO Vesterberg
Jan 1, 1995·Occupational and Environmental Medicine·B K LeeK D Ahn
Aug 4, 2004·Environmental Health Perspectives·Shirng-Wern TsaihHoward Hu
Jun 1, 1988·Environmental Health Perspectives·H M PerryE F Perry
Jun 1, 1988·Environmental Health Perspectives·P C ElwoodC Toothill
Jun 1, 1988·Environmental Health Perspectives·R P Wedeen
Jun 1, 1988·Environmental Health Perspectives·W R Harlan
Jun 1, 1988·Environmental Health Perspectives·S J KoppJ P Tow
Jun 1, 1990·Environmental Health Perspectives·R A Goyer
Aug 16, 2006·Journal of Zhejiang University. Science. B·Sohaila RahmanMohammad Zafar Iqbal
Dec 6, 2003·Archives of Environmental Health·Sayo O Fakayode, Iromidayo B Olu-Owolabi
Dec 19, 2009·Environmental Health Perspectives·Chadi YazbeckGuy Huel
Jun 1, 1988·Environmental Health Perspectives·D S SharpT Johnston
Jun 1, 1988·Environmental Health Perspectives·W C Cooper
Nov 1, 1987·British Journal of Industrial Medicine·D K ParkinsonM M Connell
Sep 25, 1997·Environmental Health Perspectives·M Loghman-Adham
Jan 1, 1988·Journal of Toxicology. Clinical Toxicology·B P Bernard, C E Becker
Apr 1, 1993·The American Journal of the Medical Sciences·V Batuman
Dec 20, 2007·The American Journal of the Medical Sciences·Jhumka Ghosh-NarangVecihi Batuman
Jun 18, 2004·The American Journal of the Medical Sciences·Ursula C Brewster, Mark A Perazella
Sep 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·V BatumanM Naumoff
Jun 1, 1990·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C MorrisW M Bennett
Jun 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G Eknoyan
Jan 1, 1984·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R P Wedeen
Sep 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R E QualheimR G Luke
Sep 20, 2007·Industrial Health·Orawan KaewboonchooToshio Kawai
Oct 26, 2006·Kidney International·E B EkongV M Weaver
Feb 1, 1988·Kidney International·F L Van de VyverM E De Broe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.